Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cardiovascular Drugs and Therapy

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s10557-017-6752-zPMID 28956198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy

  2017cited by this paper
• Interleukin 6 Inhibition and Coronary Artery Disease in a High‐Risk Population: A Prospective Community‐Based Clinical Study

  2017cited by this paper
• Association of NT-proBNP and interleukin-17 levels with heart failure in elderly patients.

  2016cited by this paper
• Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum".

  2016cited by this paper
• Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis

  2016cited by this paper
• Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure Progression

  2016cited by this paper
• Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.

  2015cited by this paper
• Galectin‐3 in patients with heart failure with preserved ejection fraction: results from the Aldo‐DHF trial

  2015cited by this paper
• TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin.

  2015cited by this paper
• Innate immune system cells in atherosclerosis.

  2014cited by this paper
• Mitochondria selective S-nitrosation by mitochondria-targeted S-nitrosothiol protects against post-infarct heart failure in mouse hearts

  2014cited by this paper
• CD4+ T Cells Promote the Transition From Hypertrophy to Heart Failure During Chronic Pressure Overload

  2014cited by this paper
• IL-6 signalling in patients with acute ST-elevation myocardial infarction.

  2014cited by this paper
• Prognostic value of circulating regulatory T cells for worsening heart failure in heart failure patients with reduced ejection fraction.

  2014cited by this paper
• Predictive power of the fractalkine receptor CX3CR1 on CD4 T cells in patients with chronic heart failure.

  2014cited by this paper
• Impaired Autophagy Contributes to Adverse Cardiac Remodeling in Acute Myocardial Infarction

  2014cited by this paper
• TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases

  2014cited by this paper
• Heart failure: preventing disease and death worldwide

  2014cited by this paper
• Innate immune receptors in heart failure: Side effect or potential therapeutic target?

  2014cited by this paper
• The inflammatory response in myocardial injury, repair, and remodelling

  2014cited by this paper
• Increased (99m)Tc-sestamibi washout reflects impaired myocardial contractile and relaxation reserve during dobutamine stress due to mitochondrial dysfunction in dilated cardiomyopathy patients.

  2013cited by this paper
• Regulation of autophagy and apoptosis in response to angiotensin II in HL-1 cardiomyocytes.

  2013cited by this paper
• The pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondria.

  2013cited by this paper
• Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis

  2013cited by this paper
• Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown.

  2013influential reference
• Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.

  2013cited by this paper
• Interleukin-1β induces a reversible cardiomyopathy in the mouse

  2013cited by this paper
• Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure

  2013cited by this paper
• Advanced glycation end products-induced reactive oxygen species generation is partly through NF-kappa B activation in human aortic endothelial cells.

  2013cited by this paper
• LOX-1 deletion and macrophage trafficking in atherosclerosis.

  2013cited by this paper
• p53-PGC-1α Pathway Mediates Oxidative Mitochondrial Damage and Cardiomyocyte Necrosis Induced by Monoamine Oxidase-A Upregulation: Role in Chronic Left Ventricular Dysfunction in Mice

  2013cited by this paper
• Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure

  2012cited by this paper
• The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

  2012cited by this paper
• Activation of CD4+ T Lymphocytes Improves Wound Healing and Survival After Experimental Myocardial Infarction in Mice

  2012cited by this paper
• Cytokine Therapy With Interleukin-2/Anti–Interleukin-2 Monoclonal Antibody Complexes Expands CD4+CD25+Foxp3+ Regulatory T Cells and Attenuates Development and Progression of Atherosclerosis

  2012cited by this paper
• Potential Involvement of LOX-1 in Functional Consequences of Endothelial Senescence

  2011cited by this paper
• Oxidized LDL, LOX-1 and Atherosclerosis

  2011cited by this paper
• Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity

  2011cited by this paper
• The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls.

  2011cited by this paper
• Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction

  2011cited by this paper
• Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion.

  2011cited by this paper
• Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22–dependent intestinal pathology

  2011cited by this paper
• Mitochondrial reactive oxygen species drive proinflammatory cytokine production

  2011cited by this paper
• Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha.

  2010cited by this paper
• Continuous Glycoprotein-130-Mediated Signal Transducer and Activator of Transcription-3 Activation Promotes Inflammation, Left Ventricular Rupture, and Adverse Outcome in Subacute Myocardial Infarction

  2010cited by this paper
• Profound Cardioprotection With Chloramphenicol Succinate in the Swine Model of Myocardial Ischemia-Reperfusion Injury

  2010cited by this paper
• Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner.

  2010cited by this paper
• Tumor necrosis factor-&agr; decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes*

  2010cited by this paper
• Defective DNA Replication Impairs Mitochondrial Biogenesis In Human Failing Hearts

  2010cited by this paper
• Targeting Toll-like receptors: emerging therapeutics?

  2010cited by this paper
• Tumor necrosis factor-alpha produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload.

  2010cited by this paper
• l-Carnitine is essential to β-oxidation of quarried fatty acid from mitochondrial membrane by PLA2

  2010cited by this paper
• Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.

  2010cited by this paper
• Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis.

  2010cited by this paper
• Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.

  2009cited by this paper
• LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells.

  2009cited by this paper
• Autophagy in Ischemic Heart Disease

  2009cited by this paper
• Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase.

  2009cited by this paper
• The role of autophagy in the heart

  2009cited by this paper
• Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

  2009cited by this paper
• Divergent Tumor Necrosis Factor Receptor-Related Remodeling Responses in Heart Failure: Role of Nuclear Factor-&kgr;B and Inflammatory Activation

  2009cited by this paper
• PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart.

  2009cited by this paper
• Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.

  2009cited by this paper
• Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.

  2009cited by this paper
• Post-infarct remodelling: contribution of wound healing and inflammation

  2008cited by this paper
• Origin and physiological roles of inflammation

  2008cited by this paper
• LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice.

  2008cited by this paper
• Role of gp130‐mediated signalling pathways in the heart and its impact on potential therapeutic aspects

  2008cited by this paper
• Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure.

  2008influential reference
• Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling.

  2008cited by this paper
• Overexpression of TGFbeta1 by adeno-associated virus type-2 vector protects myocardium from ischemia-reperfusion injury.

  2008cited by this paper
• Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy

  2007cited by this paper
• Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet

  2007cited by this paper
• Expression of interferon-gamma and interleukin-4 production in CD4+ T cells in patients with chronic heart failure.

  2007cited by this paper
• Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis

  2007cited by this paper
• Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies.

  2007cited by this paper
• Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis

  2007cited by this paper
• Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes.

  2007cited by this paper
• The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress

  2007cited by this paper
• Cardiac fibroblasts influence cardiomyocyte phenotype in vitro.

  2007cited by this paper
• Expression of interferon-g and interleukin-4 production in CD4+ T cells in patients with chronic heart failure

  2007cited by this paper
• CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice.

  2006cited by this paper
• IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes.

  2006cited by this paper
• Effects of Thalidomide Treatment in Heart Failure Patients

  2006cited by this paper
• MyD88 and NOS2 are essential for toll-like receptor 4-mediated survival effect in cardiomyocytes.

  2006cited by this paper
• Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction.

  2006cited by this paper
• Autophagic Degeneration and Death of Cardiomyocytes in Heart Failure

  2006cited by this paper
• Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure.

  2006cited by this paper
• Septic cardiomyopathy - A not yet discovered cardiomyopathy?

  2006cited by this paper
• Oxidative Stress Causes Heart Failure with Impaired Mitochondrial Respiration*

  2006cited by this paper
• Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice

  2005cited by this paper
• Autophagy in cell death: an innocent convict?

  2005cited by this paper
• Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients.

  2005cited by this paper
• Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

  2005cited by this paper
• Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium.

  2005cited by this paper
• Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.

  2004cited by this paper
• Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.

  2004cited by this paper
• Pentoxifylline in ischemic, hypertensive and idiopathic‐dilated cardiomyopathy: effects on left‐ventricular function, inflammatory cytokines and symptoms

  2004cited by this paper
• Urinary biopyrrins levels are elevated in relation to severity of heart failure.

  2004cited by this paper
• Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity.

  2004cited by this paper

• Contribution of genetic variability of the proinflammatory cytokine system to the development of long QT syndrome

  2026cites this paper
• The interplay between DNA damage response and mitochondrial dysfunction in radiotherapy

  2025cites this paper
• Unveiling naringenin's therapeutic potential in a rat model of postmenopausal cardiovascular complications: integrated in silico and in vivo experimental approaches.

  2025cites this paper
• Systematic Review and Meta-Analysis of Early Detection of Myocardial Injury: Advances in Biomarker-Based Risk Stratification and Diagnostic Precision

  2025cites this paper
• Inflammatory cytokines and cardiac arrhythmias: from pathogenesis to potential therapies

  2025cites this paper
• Implications of Oxidative Stress in the Pathophysiological Pathways of Heart Failure

  2025cites this paper
• Molecular mechanisms for pathophysiology and therapy of cardiac dysfunction in heart failure

  2025cites this paper
• Correlation Between Serum Apolipoprotein A and Clinical Outcome in Patients with Non-ischemic Heart Failure

  2025cites this paper
• Identification of Necroptosis and Immune Infiltration in Heart Failure Through Bioinformatics Analysis

  2025cites this paper
• Immunomodulatory Effects of Ticagrelor in Myocardial Infarction: Shifting the Cytokine Balance Toward an Anti-Inflammatory Profile

  2025cites this paper
• Methyl 3-Bromo-4,5-dihydroxybenzoate Attenuates Inflammatory Bowel Disease by Regulating TLR/NF-κB Pathways

  2025cites this paper
• Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure

  2024cites this paper
• Bioactive compounds,quercetin, curcumin and β-glucan,regulate innate immunity via the gut-liver-brain axis

  2024cites this paper
• The Insight into the Role of Leptin and Its Receptor in Heart Failure with Preserved Ejection Fraction

  2024cites this paper
• Environmental behavior and toxic effects of micro(nano)plastics and engineered nanoparticles on marine organisms under ocean acidification: a review.

  2024cites this paper
• Alleviating hypoxia and oxidative stress for treatment of cardiovascular diseases: a biomaterials perspective.

  2024cites this paper
• The involvement of reactive oxygen species in causing chronic cardiovascular and neurodegenerative diseases and some cancers

  2024cites this paper
• Association between skeletal muscle and left ventricular mass in patients with hyperthyroidism

  2024cites this paper
• Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis

  2023cites this paper
• Targeting Key Inflammatory Mechanisms Underlying Heart Failure: A Comprehensive Review

  2023cites this paper
• GSTM2 alleviates heart failure by inhibiting DNA damage in cardiomyocytes

  2023cites this paper
• Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4

  2023cites this paper
• Enhanced cardioprotective activity of ferulic acid-loaded solid lipid nanoparticle in an animal model of myocardial injury.

  2023cites this paper
• A Scoping Review Using the Theory of Unpleasant Symptoms

  2023cites this paper
• Reappraising the role of chronic inflammatory burden in heart failure

  2023cites this paper
• APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure

  2023cites this paper
• Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction

  2023cites this paper
• Liensinine alleviates septic heart injury by targeting inflammation, oxidative stress, apoptosis, and autophagy

  2023cites this paper
• Effects of dandelion root on rat heart function and oxidative status

  2023cites this paper
• Enhanced neutrophil extracellular traps formation in AF patients with dilated left atrium

  2023cites this paper
• Cardiorenal syndrome: long road between kidney and heart

  2022cites this paper
• Biomarkers in Heart Failure: From Research to Clinical Practice

  2022cites this paper
• Echocardiographic Markers of Mild Pulmonary Hypertension are not Correlated with Worse Respiratory Outcomes in Infants with Bronchiolitis

  2022cites this paper
• Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review

  2022cites this paper
• Cardiac function in bronchiolitis: Not only a right ventricle matter

  2022cites this paper
• Identifying the Effect of Nuanxin Capsules on Myocardial Injury Induced by Chronic Hypoxia via Network Pharmacology Analysis and Experimental Validation

  2022cites this paper
• Fatigue in Heart Failure

  2022cites this paper
• Naltrexone-Induced Cardiac Function Improvement is Associated With an Attenuated Inflammatory Response and Lipid Perioxidation in Volume Overloaded Rats

  2022cites this paper
• Future scope and challenges for congestive heart failure: Moving towards development of pharmacotherapy.

  2022cites this paper
• Melatonin protected against myocardial infarction injury in rats through a Sirt6-dependent antioxidant pathway.

  2022cites this paper
• Investigation of the Potential Key Genes and the Multitarget Mechanisms of Polygonum cuspidatum against Heart Failure Based on Network Pharmacology and Experimental Validation

  2022cites this paper
• Fish oil supplementation and physical exercise during the development period increase cardiac antioxidant capacity in Wistar rats

  2022cites this paper
• Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway

  2022cites this paper
• Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure

  2021cites this paper
• Moxibustion Improves Chronic Heart Failure by Inhibiting Autophagy and Inflammation via Upregulation of mTOR Expression

  2021cites this paper
• Yixin-Shu Capsules Ameliorated Ischemia-Induced Heart Failure by Restoring Trx2 and Inhibiting JNK/p38 Activation

  2021cites this paper
• Electroimmunology and cardiac arrhythmia

  2021cites this paper
• NETosis as a Pathogenic Factor for Heart Failure

  2021cites this paper
• Moderate offspring exercise offsets the harmful effects of maternal protein deprivation on mitochondrial function and oxidative balance by modulating sirtuins.

  2021cites this paper
• Immunological Window of Myocardial Infarction

  2021cites this paper
• Se Alleviated Oxidative Stress-Mediated Complex Poisoning Mechanism in Pb-Treated Chicken Kidneys: Inflammation, Heat Shock Response, and Autophagy

  2021cites this paper
• 5-Methoxytryptophan attenuates postinfarct cardiac injury by controlling oxidative stress and immune activation.

  2021cites this paper
• Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress

  2021cites this paper
• Identification of biomarkers, pathways and potential therapeutic targets for heart failure using bioinformatics analysis

  2021cites this paper
• Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection

  2021cites this paper
• Selenium Alleviated Oxidative Stress-Mediated Complex Poisoning Mechanism in Lead-Treated Chicken Kidneys: Inflammation, Heat Shock Response, and Autophagy

  2021cites this paper
• ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress

  2021cites this paper
• Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial

  2021cites this paper
• Quantitative Determination of Rutin in Biological Samples of Rats Upon Administration of Primula veris L. Herbal Dense Extract

  2021cites this paper
• Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure

  2020cites this paper
• The cardiovascular protective effect and mechanism of calycosin and its derivatives.

  2020cites this paper
• miR-146a in Cardiovascular Diseases and Sepsis: An Additional Burden in the Inflammatory Balance?

  2020cites this paper
• Protective Effects of a Discontinuous Treatment with Alpha-Lipoic Acid in Obesity-Related Heart Failure with Preserved Ejection Fraction, in Rats

  2020cites this paper
• Rejection-associated Mitochondrial Impairment After Heart Transplantation

  2020cites this paper
• Serum high-density lipoprotein cholesterol serves as a prognostic marker for light-chain cardiac amyloidosis.

  2020cites this paper
• Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease

  2020cites this paper
• miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis

  2020cites this paper
• Involvement of glutathione peroxidases in the occurrence and development of breast cancers

  2020cites this paper
• Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis.

  2020cites this paper
• Increased level of Urinary 8-oxo-Gsn in Patients with Heart Failure

  2020cites this paper
• LncRNA promoted inflammatory response in ischemic heart failure through regulation of miR-455-3p/TRAF6 axis

  2020cites this paper
• The Thyroid-Oxidative Stress Axis in Heart Failure

  2020cites this paper
• The Elabela-APJ axis: a promising therapeutic target for heart failure

  2020cites this paper
• Evaluation of high‐sensitivity C‐reactive protein and uric acid in vericiguat‐treated patients with heart failure with reduced ejection fraction

  2020cites this paper
• Temporal patterns of macrophage‐ and neutrophil‐related markers are associated with clinical outcome in heart failure patients

  2020cites this paper
• Effects of Lycium barbarum L. Polysaccharides on Inflammation and Oxidative Stress Markers in a Pressure Overload-Induced Heart Failure Rat Model

  2020cites this paper
• Zingerone attenuates aortic banding‐induced cardiac remodelling via activating the eNOS/Nrf2 pathway

  2019cites this paper
• Pharmacological Inhibition of Serine Proteases to Reduce Cardiac Inflammation and Fibrosis in Atrial Fibrillation

  2019cites this paper
• Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype

  2019cites this paper
• Mechanisms supporting potential use of bone marrow-derived mesenchymal stem cells in psychocardiology.

  2019cites this paper
• Antioxidant and Anti-inflammatory Effects of Ethanol Extract of Aster yomena in RAW 264.7 Macrophages

  2019cites this paper
• A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease

  2019cites this paper
• Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status

  2019cites this paper
• Integrating Pharmacokinetics Study, Network Analysis, and Experimental Validation to Uncover the Mechanism of Qiliqiangxin Capsule Against Chronic Heart Failure

  2019cites this paper
• Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation

  2019cites this paper
• Glutathione Transferase P1 Polymorphism Might Be a Risk Determinant in Heart Failure

  2019cites this paper
• Investigating the onset of insulin resistance and non-alcoholic fatty liver disease in obesity-induced cardiac dysfunction

  2019cites this paper
• Qiliqiangxin attenuates oxidative stress-induced mitochondrion-dependent apoptosis in cardiomyocytes via PI3K/AKT/GSK3β signaling pathway.

  2019cites this paper
• Effect of co-administration of Linggui zhugan decoction and Western medicine on inflammatory cytokines, and immune and cardiac functions of patients with chronic heart failure

  2019cites this paper
• Genetic Polymorphisms in Sepsis and Cardiovascular Disease: Do Similar Risk Genes Suggest Similar Drug Targets?

  2019cites this paper
• Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care

  2019cites this paper
• Bcl6 knockdown aggravates hypoxia injury in cardiomyocytes via the P38 pathway

  2019cites this paper
• Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats

  2018cites this paper
• 3,5-Dicaffeoylquinic acid protects H9C2 cells against oxidative stress-induced apoptosis via activation of the PI3K/Akt signaling pathway

  2018cites this paper
• Matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration

  2018cites this paper
• Inflammation and atrial fibrillation: A comprehensive review

  2018cites this paper
• Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes

  2018cites this paper
• Influence of exercise on oxidative stress in patients with heart failure

  2018cites this paper
• The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol—study protocol

  2018cites this paper
• Prenatal inflammation exposure-programmed cardiovascular diseases and potential prevention.

  2018cites this paper